Management of systemic mastocytosis is an emerging challenge which requires a multidisciplinary diagnostic approach and personalized treatment strategy. Midostaurin can rapidly reduce the disease burden, also in cladribine refractory cases.
A case of aggressive systemic mastocytosis with bulky lymphadenopathy showing response to midostaurin / M. Sciume, F. Serpenti, S. Muratori, V. Pravettoni, F.M. Ulivieri, G.A. Croci, A.C. Migliorini, A. Esposito, M.C. Goldaniga, G.N. Saporiti, G. Galassi, L. Baldini, F. Onida, F.I. Grifoni. - In: CLINICAL CASE REPORTS. - ISSN 2050-0904. - 9:2(2021 Feb), pp. 978-982. [10.1002/ccr3.3717]
A case of aggressive systemic mastocytosis with bulky lymphadenopathy showing response to midostaurin
F. SerpentiSecondo
;G.A. Croci;A. Esposito;G.N. Saporiti;L. Baldini;F. OnidaPenultimo
;
2021
Abstract
Management of systemic mastocytosis is an emerging challenge which requires a multidisciplinary diagnostic approach and personalized treatment strategy. Midostaurin can rapidly reduce the disease burden, also in cladribine refractory cases.
File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
Clinical Case Reports - 2021 - Scium - A case of aggressive systemic mastocytosis with bulky lymphadenopathy showing.pdf
accesso aperto
Tipologia:
Publisher's version/PDF
Dimensione
703.14 kB
Formato
Adobe PDF
|
703.14 kB | Adobe PDF | Visualizza/Apri |
Pubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
